-55%

est. 2Y upside i

Series D+

Stage: exit. Country: Germany

Rank

#3325

Sector

Elder and Disabled Care

Est. Liquidity

~3Y

Data Quality

Data: Low

Talea lacks essential financial data (revenue, valuation, funding) to estimate equity upside.

Last updated: July 3, 2026

Bull (10%)0%

No upside projection possible due to missing financial data. Assumes favorable exit at current unknown valuation.

Base (35%)0%

Central case assumes no material change, but data gap prevents reliable estimate.

Bear (55%)-100%

Worst case: common equity worthless due to lack of liquidity, stale valuation, and high incumbent threat. Exit below any assumed preference.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Funding Intensity

0%

No data on total funding or valuation; preference overhang cannot be assessed.

Dilution Risk

high

No recent funding round since 2019; likely need for capital in the next 24 months, causing significant dilution.

Secondary Liquidity

none

No secondary market transactions reported; common stock likely illiquid.

Questions to Ask at the Interview

Strategic questions based on Talea's data — designed to show you've done your homework.

  • 1

    “How does Talea plan to expand beyond Berlin and what are the unit economics of a typical care contract?”

  • 2

    “What is the current cap table and expected dilution for new hires?”

  • 3

    “How does Talea's digital platform differentiate from competitors like Kenbi and Careship in terms of patient outcomes?”

Community

Valuation Sentiment

Our model estimates -55% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.